Long-acting treatment options for HIV are a novel in the fight against the virus and offer people living with HIV valuable new choices for how they manage their care. Advances in the laboratory must be implemented at the last mile of healthcare delivery, which is why the work being done by the CARES team is vital to helping ensure that long-acting treatments reach people living with HIV.
Johnson & Johnson, in collaboration with ViiV Healthcare, is proud to be working alongside the JCRC team to help generate this critical data, which is investigating the impact on care and treatment outcomes for patients. We are proud of the work done so far and wish the team all the best as this study progresses.
Dr. Fafa Addo Boateng
Director, Data & Evidence Generation and Study/Molecule Responsible Physician
on behalf of Janssen Pharmaceutical Companies of Johnson & Johnson
Director Data and Evidence Generatiion
Global Trial Leader
Clinical Research Manager- Evidence Generation Team Global Public Health, J&J
Social and Implementation Scientist
Evidence Generation Program Manager, Medical Affairs